Results 21 to 30 of about 118,635,816 (237)
Journal of Medical Case Reports, 2021 Background Acquired hemophilia A is a rare coagulopathy caused by inhibitors of blood coagulation factor VIII. Patients with acquired hemophilia A have a higher mortality risk (5–10%) than those with congenital hemophilia.
Keigo Maeda +3 more
doaj +1 more source
Surgical Case Reports, 2023 Background Acquired hemophilia A (AHA) is a rare disease characterized by a prolonged activated partial thromboplastin time (aPTT) and the production of coagulation factor VIII inhibitors.
Hidemasa Kubo +8 more
doaj +1 more source
Acquired Hemophilia ‘A’ – An Uncommon Condition Presented with Common Manifestations
National Board of Examinations Journal of Medical Sciences, 2023 Hemophilia A is usually a congenital bleeding disorder, which manifest in males due to its X linked recessive pattern of inheritance. It commonly presents with bruises, uncontrolled bleeding post minor trauma or post circumcision, knee swelling etc ...
Deepak S. Laddhad +4 more
doaj +1 more source
The problem of acquired hemophilia [PDF]
Blood, 2015 In this issue of Blood , Andreas Tiede et al report the results of a German, Austrian, and Swiss registry (GTH-AH study) of acquired hemophilia and identify prognostic factors that may guide the choice of immunosuppressive treatment (IST) to eradicate the autoantibody contributing to the outcome ...
Francesco Baudo, Francesco de Cataldo
openaire +2 more sources
Acquired hemophilia A following COVID-19 vaccine: a case report
Journal of Medical Case Reports, 2023 Background In the literature, reported cases of Acquired hemophilia A (AHA) induced by COVID-19 vaccination occurred after Adenoviral Vector Deoxyribonucleic Acid (DNA)- and SARS-CoV-2 Messenger Ribonucleic acid (mRNA)-Based vaccines.
Bouselama Emna +8 more
doaj +1 more source
Spontaneous bleeding in a patient with malignant lymphoma: A case of acquired hemophilia [PDF]
, 2000 Background: Acquired hemophilia is a rare condition which can be associated with lymphoproliferative disease. Case Report: Eleven yea rs after the diagnosis of immunocytoma had been made, a 72-year-old man developed a high-titer factor VIII inhibitor. At
Brack, N. +5 more
core +1 more source
Laboratory work-up of acquired hemophilia A [PDF]
, 2022 The paper presents the major aspects of laboratory diagnosis of acquired hemophilia A (AHA). The author discusses the difficulties encountered in the process of detecting this coagulopathy.
Odnoczko, Edyta; Department of Hemostasis and Metabolic Disorders Institute of Hematology and Transfusion Medicine in Warsaw +1 more
core +1 more source
A case of acquired hemophilia A and bullous pemphigoid following SARS-CoV-2 mRNA vaccination
Journal of the Formosan Medical Association, 2022 Acquired hemophilia is a rare disease resulting from autoantibodies against endogenous factor VIII (FVIII), which associates with bleeding and a high mortality rate. The pathophysiology is still unclear.
Pei-An Fu +5 more
doaj +1 more source
A single-center retrospective clinical study of 7 cases of acquired hemophilia A [PDF]
Zhenduanxue lilun yu shijianObjective This study aims to explore the etiology, clinical manifestations, diagnosis and treatment, and prognosis of acquired hemophilia A (AHA), and to improve the clinical understanding, diagnosis, and treatment of AHA.
QIAN Lingling, PEI Xiaoping, SUN Aihong, HEI Bin, SUN Mei
doaj +1 more source
Immunoadsorption for the Treatment of Acquired Hemophilia: New Observational Data, Systematic Review, and Meta-Analysis. [PDF]
, 2021 The treatment of patients with acquired hemophilia is challenging due to life-threatening hemorrhages, delayed response, and adverse effects to immunosuppressive agents. Even though immunoadsorption (IA) rapidly removes autoantibodies against factor VIII,
Daskalakis, Michael +13 more
core +2 more sources